Kyntra Bio (KYNB) Inventory Average (2019 - 2026)
Kyntra Bio's (KYNB) quarterly Inventory Average came in at $3.4 million in Q2 2026, down 3.56% year-over-year from $3.5 million in Q2 2025, and down 5.04% quarter-over-quarter from $3.6 million in Q1 2026.
Analysis
Kyntra Bio (KYNB) Inventory Average (2019 - 2026) Analysis & Trends
Kyntra Bio has disclosed Inventory Average across 8 years of filings, most recently posting $3.4 million for Q2 2026.
- In Q2 2026, Inventory Average fell 3.56% year-over-year to $3.4 million; the TTM figure through Jun 2026 stood at $3.4 million (down 3.56% YoY), while the FY2025 annual figure was $3.4 million, down 66.07% from the prior year.
- Inventory Average came in at $3.4 million for Q2 2026 at Kyntra Bio, down from $3.6 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $42.0 million in Q2 2022 to a low of $3.2 million in Q1 2025.
- Average Inventory Average over 5 years is $23.4 million, with a median of $25.5 million recorded in 2024.
- Year-over-year, Inventory Average jumped 98.64% in 2022 and plunged 86.69% in 2025.
- Over 5 years, Inventory Average stood at $40.2 million in 2022, then retreated by 28.01% to $28.9 million in 2023, then tumbled by 53.18% to $13.5 million in 2024, then plunged by 71.92% to $3.8 million in 2025, then decreased by 11.03% to $3.4 million in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $3.4 million in Q2 2026, $3.6 million in Q1 2026, and $3.8 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 6.20 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 1.93 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 3.09 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 213.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 2.17 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Kyntra Bio | 32.30 Mn | 32.30 Mn | 1.47 Mn | 3.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.38 Mn |
| Mar 31, 2026 | 3.56 Mn |
| Dec 31, 2025 | 3.80 Mn |
| Sep 30, 2025 | 3.86 Mn |
| Jun 30, 2025 | 3.51 Mn |
| Mar 31, 2025 | 3.16 Mn |
| Dec 31, 2024 | 13.55 Mn |
| Sep 30, 2024 | 24.67 Mn |
| Jun 30, 2024 | 26.37 Mn |
| Mar 31, 2024 | 22.25 Mn |
| Dec 31, 2023 | 28.93 Mn |
| Sep 30, 2023 | 40.94 Mn |
| Jun 30, 2023 | 41.82 Mn |
| Mar 31, 2023 | 41.45 Mn |
| Dec 31, 2022 | 40.19 Mn |
| Sep 30, 2022 | 40.42 Mn |
| Jun 30, 2022 | 41.98 Mn |
| Mar 31, 2022 | 37.04 Mn |
| Dec 31, 2021 | 30.17 Mn |
| Sep 30, 2021 | 26.92 Mn |